Showing results (1831-1840 of 2,276) with videos related to

Sort By:
Pageof 228
JAMA Oncology|February 26, 2016
Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and VulvaBrooke E Howitt, Heather H Sun, Margaretha G M Roemer, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
Azole-based inhibitors of AKT/PKB for the treatment of cancerQingping Zeng, John G Allen, Matthew P Bourbeau, et al.
Human Mutation|November 30, 2020
Verifying nomenclature of DNA variants in submitted manuscripts: Guidance for journalsJan Higgins, Raymond Dalgleish, Johan T den Dunnen, et al.
Nature Immunology|October 2, 2007
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunctionDaniel E Kaufmann, Daniel G Kavanagh, Florencia Pereyra, et al.
Cancer Immunology Research|August 26, 2024
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor ImmunityPeter Georgiev, SeongJun Han, Amy Y Huang, et al.
Cell Reports|December 2, 2014
CD161 defines a transcriptional and functional phenotype across distinct human T cell lineagesJoannah R Fergusson, Kira E Smith, Vicki M Fleming, et al.
Cell Research|November 12, 2025
Targeted destruction of VISTA boosts anti-tumor immunotherapyLi Chen, Xia Bu, Yishuang Sun, et al.
Genome Biology|October 16, 2020
Clonal tracing reveals diverse patterns of response to immune checkpoint blockadeShengqing Stan Gu, Xiaoqing Wang, Xihao Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical TrialJean-Christophe Pignon, Opeyemi Jegede, Sachet A Shukla, et al.
Physical Review Letters|October 21, 2022
Quenching of Single-Particle Strength in A=15 NucleiB P Kay, T L Tang, I A Tolstukhin, et al.
Pageof 228